BioSpace News Archive

Business

Sera Prognostics Announces The Appointment Of Zhenya Lindgardt To The Board

Sera Prognostics Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced that Zhenya Lindgardt has joined the Sera Board of Directors.

November 8, 2021
·
6 min read
Business

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021

Amphastar Pharmaceuticals, Inc. reported results for the three months ended September 30, 2021.

November 8, 2021
·
9 min read
Genetown

ProQR Announces Upcoming Investor Conferences in November and December

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, announced that Company management will participate in the following upcoming investor conferences

November 8, 2021
·
2 min read
Deals

MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

November 8, 2021
·
2 min read
Business

Nyxoah appoints new CFO

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced that Loïc Moreau will join Nyxoah as CFO as of January 1, 2022.

November 8, 2021
·
2 min read
Biotech Bay

Atreca to Present at Upcoming Virtual Investor Conferences - Nov 08, 2021

Atreca, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced that it will present at the following upcoming virtual investor conferences.

November 8, 2021
·
2 min read
Business

BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021

BioCardia®, Inc. [NASDAQ:BCDA], a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it will release third quarter 2021 financial results on Wednesday, November 10, 2021 at 4:30PM ET.

November 8, 2021
·
1 min read
Business

Certara Appoints James E. Cashman III as Chairman of Board of Directors

Certara, Inc., a global leader in biosimulation, announced that James E. Cashman III, a current Board member, will be appointed Chairman of the Board of Directors, effective as of December 1, 2021.

November 8, 2021
·
1 min read
Business

Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (“Imagin” or the “Company”), a surgical imaging company visualizing cancer in vital new ways starting with bladder cancer, today reported key changes in the composition of its Board of Directors.

November 8, 2021
·
4 min read
Deals

Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition authorities in Germany and Austria.

November 8, 2021
·
7 min read